T145
High dose IL-2 (HD IL-2) has been extensively used as an immunotherapy against metastatic melanoma However, why HD IL-2 is effective only in a subset of patients and whether predictive biomarkers, before or early during the course of therapy, can be used to improve response rates remain unresolved....
| Hoofdauteurs: | , , , , , , , , , , |
|---|---|
| Formaat: | Artikel |
| Taal: | English |
| Gepubliceerd in: |
Elsevier
2015-11-01
|
| Reeks: | EJC Supplements |
| Online toegang: | http://www.sciencedirect.com/science/article/pii/S1359634915000993 |